In addition to conducting research with one of our primary faculty members, postdoctoral scholars can contribute in the classroom as educators and in the service domain on departmental and institutional committees. Postdoctoral training can be tailored to optimally prepare postdoctoral scholars for the next phase in their careers. Our past postdoctoral scholars are now applying their training in academia, industry, medical settings, and government. We are excited to play a key role in developing the next generation of scientists, educators, and medical professionals, and are happy to make postdoctoral training a highly individualized and optimized experience.
Check below for more information on postdoctoral openings available in the Department of Pharmacology.
Tanya Freedman, PhD - The Freedman lab studies feedback signaling mechanisms that regulate thresholds for immune-cell activation in tissue homeostasis, antibacterial immunity, autoimmune disease, and the tumor microenvironment.
Hai Dang Nguyen, PhD - The Dang lab is building an interdisciplinary team of researchers to elucidate how our DNA is repaired to prevent genomic instability and ultimately to develop novel therapeutic strategies in cancer therapy. A current focus in the lab is to identify novel targets in the DNA damage response pathway for treating patients harboring spliceosome mutations such as myelodysplastic syndromes and other solid tumors.
Marco Pravetoni, PhD - The Pravetoni lab is interested in development of vaccines and antibody-based therapeutics to treat opioid use disorders and opioid-related overdoses. Our multidisciplinary research program integrates rational vaccine design, immunomodulators, formulation/delivery platforms, pre-clinical models, analysis of Band T cell lymphocyte repertoire, GLP/GMP studies to support regulatory approval and clinical evaluation, and industry collaborations.
The Pravetoni lab is seeking postdocs interested in the development of vaccines and antibody-based therapeutics to reduce opioid use disorders and opioid-related overdoses. Our unique multidisciplinary research program integrates rational vaccine design, immunomodulators, formulation/delivery platforms, pre-clinical models, analysis of B and T cell lymphocyte repertoire, GLP/GMP studies to support regulatory approval and clinical evaluation, and ad hoc industry collaborations. Our team is currently planning a Phase I clinical trial of vaccines targeting opioids. Strategies and platforms are currently applied to development of vaccines or antibodies to counteract fentanyl, fentanyl analogs, as well as other chemical threats. We are seeking an independent and motivated colleague interested in leading multidisciplinary projects as well as team efforts.
Li-Na Wei, PhD - The Wei lab is interested in the mechanisms of neuro-endocrine/neuro-immune regulation and communication via exosomes, particularly those underlying neurodegenerative and inflammatory diseases. The lab is also interested in drug discovery for new therapeutic targets identified from these studies. Experimental systems/methods include gene-targeted mice, primary cell and 3D-organ cultures, and molecular biology/biochemistry/immunology.
Kevin Wickman, PhD - Postdoctoral positions are available for enthusiastic individuals interested in molecular and cellular mechanisms underlying neuronal excitability, with a specific emphasis on those relevant to addiction and mood. Our NIH-funded research programs incorporate techniques in electrophysiology, intracranial pharmacology and genetics, neuromodulation, and behavioral analysis.
Please learn more about our lab and research interests on our website and follow us on Twitter @WickmanLab. A PhD in the biomedical sciences is required. While prior relevant experience is desirable, our lab is an excellent training environment for those interested in developing new skills. Interested applicants should send a curriculum vitae and brief statement of research interests to Dr. Kevin Wickman.